India rejects Abbott patent on Kaletra
India rejects HIV drug patent
For once no Patents please
India Allows Use of Generic Versions of Abbott AIDS Drug: Biotech’s Latest Tribulations
India rejects unmerited patent application by Abbott for HIV drug
India Rejects Patent Application for Abbott’s Kaletra
Abbott’s HIV drug patent plea rejected for lack of novelty
Abbott Laboratories HIV Drug Rejected
India Rejects Abbott patent of Kaletra AIDS drug
India rejects Abbott’s patent application for Kaletra